Sign in
4

Changes in Ownership

Axsome Therapeutics, Inc. Filed Acc 0001193125-26-045110

Director acquired 5,193 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Coleman Mark Director 2026-02-10 Option exercise +5,193 $8.02 $41,648 53,405 D
Derivatives
Coleman Mark Director 2026-02-10 Option exercise · Stock Option (Right to Buy) −5,193 0 D
Loading xslF345X05/ownership.xml…